Kraig Biocraft Laboratories, Inc financial data

Symbol
KBLB on OTC
Location
2723 South State Street, Suite 150, Ann Arbor, MI
Fiscal year end
December 31
Latest financial report
10-Q - Q1 2025 - May 15, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 10.5 % -66.7%
Quick Ratio 0.07 % 0%
Debt-to-equity -123 % +24.6%
Return On Equity 45 % -18.7%
Return On Assets -198 % -124%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.04B shares +0.41%
Entity Public Float 133M USD +214%
Weighted Average Number of Shares Outstanding, Basic 1.04B shares +0.3%
Weighted Average Number of Shares Outstanding, Diluted 1.04B shares +0.3%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 159K USD -19.9%
General and Administrative Expense 1.89M USD +34.4%
Operating Income (Loss) -3.21M USD -24.4%
Nonoperating Income (Expense) -285K USD +27.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.49M USD -17.5%
Net Income (Loss) Attributable to Parent -3.49M USD -17.5%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 397K USD -80.6%
Inventory, Net 6.88K USD 0%
Assets, Current 453K USD -78%
Property, Plant and Equipment, Net 39K USD -34.8%
Operating Lease, Right-of-Use Asset 72.6K USD -36.4%
Assets 1.32M USD -52.5%
Accrued Liabilities, Current 191K USD
Liabilities, Current 9.83M USD +9.71%
Operating Lease, Liability, Noncurrent 37.7K USD -34.9%
Liabilities 9.86M USD +9.42%
Accumulated Other Comprehensive Income (Loss), Net of Tax 13K USD
Retained Earnings (Accumulated Deficit) -53.7M USD -6.96%
Stockholders' Equity Attributable to Parent -8.55M USD -36.9%
Liabilities and Equity 1.32M USD -52.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -434K USD +11.2%
Net Cash Provided by (Used in) Financing Activities 158K USD
Common Stock, Shares, Issued 2.16M shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -276K USD +45.2%
Deferred Tax Assets, Valuation Allowance 5.34M USD +9.32%
Operating Lease, Liability 73.3K USD -36.1%
Depreciation 25.1K USD -9.44%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -3.87M USD +23%
Lessee, Operating Lease, Liability, to be Paid 85.3K USD -33.1%
Operating Lease, Liability, Current 35.5K USD -37.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7.86K USD -39.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 13K USD -74.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 12K USD -5.88%
Lessee, Operating Lease, Liability, to be Paid, Year Three 8.45K USD +15.4%
Deferred Tax Assets, Operating Loss Carryforwards 5.34M USD +9.32%
Preferred Stock, Shares Issued 0 shares
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.71K USD +29.8%
Operating Lease, Payments 15.9K USD +18.7%
Additional Paid in Capital 12.1M USD +7.41%
Preferred Stock, Shares Outstanding 0 shares